Schedule of Company’s Segment Information |
The Company’s reportable segment information was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | (in millions) | | 2025 | | | | | | | | | | | | | | | | | | | | Connected Technology Solutions | | Essential Dental Solutions | | Orthodontic and Implant Solutions | | Wellspect Healthcare | | Total | | | | | | | | | | | | | | | | | | Net sales | | $ | 243 | | | $ | 387 | | | $ | 226 | | | $ | 80 | | | $ | 936 | | | | | | | | | | | | | | | | | | | Adjusted cost of products sold (a) | | 140 | | | 138 | | | 98 | | | 33 | | | | | | | Adjusted selling expenses (b) | | 54 | | | 72 | | | 54 | | | 13 | | | | | | | Adjusted G&A expenses (b) | | 20 | | | 20 | | | 17 | | | 7 | | | | | | | Adjusted R&D expenses (c) | | 17 | | | 6 | | | 12 | | | 2 | | | | | | | | | | | | | | | | | | | | | Segment adjusted operating income | | $ | 12 | | | $ | 151 | | | $ | 45 | | | $ | 25 | | | $ | 233 | | | | | | | | | | | | | | | | | | | Reconciling items (income) expense: | | | | | | | | | | | | | | Unallocated corporate costs (d) | | | | | | | | | | $ | 68 | | | | | Interest expense, net | | | | | | | | | | 24 | | | | | Other expense (income), net | | | | | | | | | | 1 | | | | | Goodwill and intangible asset impairments | | | | | | | | | | 235 | | | | | Restructuring and other costs | | | | | | | | | | 4 | | | | | Amortization of intangibles | | | | | | | | | | 54 | | | | | Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations | | | | | | | | | | — | | | | | Loss before income taxes | | | | | | | | | | $ | (153) | | | | |
| | | (a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs. | (b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs. | (c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs. | (d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | (in millions) | | 2024 | | | | | | | | | | | | | | Connected Technology Solutions | | Essential Dental Solutions | | Orthodontic and Implant Solutions | | Wellspect Healthcare | | Total | | | | | | | | | | | | Net sales | | $ | 253 | | | $ | 375 | | | $ | 276 | | | $ | 80 | | | $ | 984 | | | | | | | | | | | | | Adjusted cost of products sold (a) | | 150 | | | 147 | | | 106 | | | 32 | | | | Adjusted selling expenses (b) | | 61 | | | 80 | | | 81 | | | 14 | | | | Adjusted G&A expenses (b) | | 20 | | | 18 | | | 33 | | | 7 | | | | Adjusted R&D expenses (c) | | 19 | | | 5 | | | 14 | | | 3 | | | | | | | | | | | | | | | Segment adjusted operating income | | $ | 3 | | | $ | 125 | | | $ | 42 | | | $ | 24 | | | $ | 194 | | | | | | | | | | | | | Reconciling items (income) expense: | | | | | | | | | | | Unallocated corporate costs (d) | | | | | | | | | | $ | 69 | | Interest expense, net | | | | | | | | | | 17 | | Other expense (income), net | | | | | | | | | | (1) | | Goodwill and intangible asset impairments | | | | | | | | | | — | | Restructuring and other costs | | | | | | | | | | 21 | | Amortization of intangibles | | | | | | | | | | 54 | | Income before income taxes | | | | | | | | | | $ | 34 | |
| | | (a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs. | (b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs. | (c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs. | (d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, | | (in millions) | | 2025 | | | | | | | | | | | | | | | | | | | | Connected Technology Solutions | | Essential Dental Solutions | | Orthodontic and Implant Solutions | | Wellspect Healthcare | | Total | | | | | | | | | | | | | | | | | | Net sales | | $ | 478 | | | $ | 740 | | | $ | 443 | | | $ | 154 | | | $ | 1,815 | | | | | | | | | | | | | | | | | | | Adjusted cost of products sold (a) | | 275 | | | 262 | | | 191 | | | 60 | | | | | | | Adjusted selling expenses (b) | | 112 | | | 142 | | | 108 | | | 26 | | | | | | | Adjusted G&A expenses (b) | | 38 | | | 38 | | | 39 | | | 13 | | | | | | | Adjusted R&D expenses (c) | | 34 | | | 11 | | | 23 | | | 5 | | | | | | | | | | | | | | | | | | | | | Segment adjusted operating income | | $ | 19 | | | $ | 287 | | | $ | 82 | | | $ | 50 | | | $ | 438 | | | | | | | | | | | | | | | | | | | Reconciling items (income) expense: | | | | | | | | | | | | | | Unallocated corporate costs (d) | | | | | | | | | | $ | 155 | | | | | Interest expense, net | | | | | | | | | | 43 | | | | | Other expense (income), net | | | | | | | | | | 1 | | | | | Goodwill and intangible asset impairments | | | | | | | | | | 235 | | | | | Restructuring and other costs | | | | | | | | | | 13 | | | | | Amortization of intangibles | | | | | | | | | | 99 | | | | | Depreciation resulting from the fair value step-up of property, plant, and equipment from business combinations | | | | | | | | | | 1 | | | | | Loss before income taxes | | | | | | | | | | $ | (109) | | | | |
| | | (a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs. | (b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs. | (c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs. | (d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, | (in millions) | | 2024 | | | | | | | | | | | | | | Connected Technology Solutions | | Essential Dental Solutions | | Orthodontic and Implant Solutions | | Wellspect Healthcare | | Total | | | | | | | | | | | | Net sales | | $ | 500 | | | $ | 739 | | | $ | 547 | | | $ | 151 | | | $ | 1,937 | | | | | | | | | | | | | Adjusted cost of products sold (a) | | 296 | | | 285 | | | 206 | | | 59 | | | | Adjusted selling expenses (b) | | 122 | | | 163 | | | 164 | | | 27 | | | | Adjusted G&A expenses (b) | | 39 | | | 39 | | | 67 | | | 13 | | | | Adjusted R&D expenses (c) | | 38 | | | 12 | | | 26 | | | 5 | | | | | | | | | | | | | | | Segment adjusted operating income | | $ | 5 | | | $ | 240 | | | $ | 84 | | | $ | 47 | | | $ | 376 | | | | | | | | | | | | | Reconciling items (income) expense: | | | | | | | | | | | Unallocated corporate costs (d) | | | | | | | | | | $ | 148 | | Interest expense, net | | | | | | | | | | 35 | | Other expense (income), net | | | | | | | | | | (8) | | Goodwill and intangible asset impairments | | | | | | | | | | 6 | | Restructuring and other costs | | | | | | | | | | 22 | | Amortization of intangibles | | | | | | | | | | 108 | | Income before income taxes | | | | | | | | | | $ | 65 | |
| | | (a) Adjusted cost of products sold represents expenses adjusted to exclude intangible amortization expense, step-up depreciation expense, and other restructuring costs. | (b) Adjusted selling and adjusted G&A expenses represent expenses adjusted to exclude intangible amortization expense, other acquisition costs, step-up depreciation expense, and other restructuring costs. | (c) Adjusted R&D expenses represent expenses adjusted to exclude other restructuring costs. | (d) Unallocated corporate costs consist of general corporate expenses including corporate headcount costs, depreciation and amortization, certain professional service fees, and other operating costs which are not assigned to a specific segment. |
Depreciation and Amortization | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | (in millions) | | 2025 | | 2024 | | 2025 | | 2024 | | | | | | | | | | Connected Technology Solutions | | 46 | | 43 | | | 89 | | 86 | Essential Dental Solutions | | 8 | | 8 | | | 17 | | 17 | Orthodontic and Implant Solutions | | 23 | | 25 | | | 42 | | 50 | Wellspect Healthcare | | 5 | | 5 | | | 7 | | 9 | All other (a) | | 6 | | 5 | | | 12 | | 10 | Total | | 88 | | 86 | | | 167 | | 172 |
(a) Includes unallocated corporate costs for depreciation and amortization. The cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | December 31, 2024 | | Provisions | | Amounts Applied | | Change in Estimates | | June 30, 2025 | | | | | | | | | | | | Connected Technology Solutions | | $ | 9 | | | $ | 3 | | | $ | (9) | | | $ | (2) | | | $ | 1 | | Essential Dental Solutions | | 11 | | | — | | | (6) | | | — | | | 5 | | Orthodontic and Implant Solutions | | 9 | | | 2 | | | (4) | | | — | | | 7 | | Wellspect Healthcare | | 3 | | | 1 | | | (2) | | | — | | | 2 | | All Other | | 1 | | | 7 | | | (7) | | | — | | | 1 | | Total | | $ | 33 | | | $ | 13 | | | $ | (28) | | | $ | (2) | | | $ | 16 | |
|